FDA's Bar Code Rule comments available; Pfizer contraceptives seized for label violations;

> The FDA is no longer accepting comments on its Bar Code Rule, but all stakeholders can review the comments submitted (Keyword: FDA-2011-N-0719). List

> Drug control agents have seized "huge quantities" of Pfizer's ($PFE) emergency contraceptive, My Pal, from two locations in India because of labeling violations. Story

> Two batches of Sterimar Isotonic, a seawater solution that helps breathing, have been recalled in the U.K., possibly contaminated with bacteria. Article

> U.K. regulators have issued a Good Manufacturing Practice certificate for Albany Molecular Research's ($AMRI) manufacturing facility in Holywell, Wales. Release

> Contract manufacturer Paragon Bioservices has landed an approximately $15 million contract from the Defense Department for developing and manufacturing the Venezuelan equine encephalitis replicon particle trivalent filovirus vaccine. Announcement

> Fake and substandard drugs are often concealed among products being shipped via circuitous routes to mask their origin. Story

> Enzymicals, a specialist in enzymatic reactions for the production of chemicals and biocatalysts, will collaborate with production-savvy Herbrand PharmaChemicals on the development and production of fine chemicals. Release

> Six specialty equipment companies have joined forces as Excellence United to provide "a comprehensive solution for the pharmaceutical supply chain," capitalizing on their joint offerings for production, development and packaging processes. Item

Suggested Articles

Popular logic says you never switch horses, or CDMOs, in the middle of the stream, but Acacia Pharma had to do that to win an FDA approval.

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.